Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTI.L Regulatory News (CTI)

  • There is currently no data for CTI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRANSFER OF LISTING

14 Jul 2020 10:09

RNS Number : 9417S
Cathay International Holdings Ld
14 July 2020
 

 

 

Cathay International Holdings Limited

("Cathay" or the "Company")

TRANSFER OF LISTING

Hong Kong, 14 July 2020 - Cathay International Holdings Limited (LSE: CTI.L), an operator and investor in the growing healthcare sector in the People's Republic of China , today announces that following the passing of a special resolution by its shareholders at the Company's general meeting held on 15 June 2020, the Company's listing category has been transferred from "premium listing (commercial company)" to "standard listing", as of 8 a.m. today.

- ENDS -

For further enquiries, please contact:

 

Cathay International Holdings Limited

Eric Siu (Finance Director) Tel: +852 2828 9289

Patrick Sung (Director and Controller)

 

SPARK Advisory Partners Limited (sponsor)

Andrew Emmott / James Keeshan Tel: +44 (0) 20 3368 3555

 

About Cathay

Cathay International Holdings Limited (LSE: CTI.L) is a main market listed investment holding company and an operator and investor in the healthcare sector in the People's Republic of China (the "PRC"). The Company and its subsidiaries (collectively the "Group") aim to leverage on investment opportunities in the growing domestic demand for high quality healthcare products in the PRC and build portfolio companies into market sector leaders with competitive edge. Cathay has already demonstrated a track record of identifying investment opportunities in this area including: Lansen, a leading specialty pharmaceutical company focused on rheumatology and dermatology in the PRC; Haizi, a company engaged in the manufacture, marketing and sale of inositol and its by-product, di-calcium phosphate; Natural Dailyhealth, a company engaged in production and sales of plant extracts for use as key active ingredients in healthcare products; and Botai, a company engaged in collagen products.

 

The Group employs approximately 1,300 people across the PRC, including over 20 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen. Cathay also has a hotel investment. For more information please visit the Company's website: www.cathay-intl.com.hk.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGCGDRRGBDGGS
Date   Source Headline
29th Jan 20187:18 amRNSLansen Change of Director
27th Dec 201712:39 pmRNSUpdate on Settlement of A Litigation
22nd Sep 201711:05 amRNSResults of Special General Meeting
19th Sep 201710:15 amRNSLansen's second share reduction plan of Starry
1st Sep 20173:11 pmRNSUpdate on Litigation against Lansen's subsidiary
30th Aug 20179:48 amRNSInterim Results for Six Months Ended 30 June 2017
30th Aug 20179:45 amRNSNotice of Special General Meeting
16th Aug 20177:00 amRNSNotice of Results
21st Jun 201711:55 amRNSResult of AGM
20th Jun 20177:00 amRNSSettlement of insurance claims received by Lansen
19th Jun 201711:54 amRNSLansen's declaration & payment of special dividend
7th Jun 201710:14 amRNSLansen's proposal to approve a special dividend
28th Apr 20177:00 amRNSAnnual Report and Accounts
7th Apr 201711:37 amRNSHoldings in Company
31st Mar 20179:50 amRNSLansen subsidiary enters distribution agreement
30th Mar 20179:20 amRNSAnnual Results for the Year Ended 31 December 2016
16th Mar 20177:00 amRNSNotice of Annual Results 2016
15th Mar 201711:57 amRNSNotification of class 2 transaction
9th Mar 20179:05 amRNSLansen's share reduction plan of Starry
20th Sep 201610:44 amRNSEntrusted Manufacturing Framework Agreement
31st Aug 20169:48 amRNSHalf-year Report
17th Aug 20167:00 amRNSNotice of Interim Results 2016
13th Jul 201611:02 amRNSResult of Lansen EGM
24th Jun 20161:15 pmRNSLansen Shares Subscription and Agreement
20th Jun 201611:17 amRNSResult of AGM
5th May 20161:00 pmRNSNotification of Transactions
5th May 20161:00 pmRNSNotification of Transactions
5th May 20161:00 pmRNSClarification Announcement - transaction in Shares
22nd Apr 20168:10 amRNSAnnual Report and Accounts
5th Apr 201610:11 amRNSDirector Appointment
30th Mar 201610:01 amRNSAnnual Results for the Year Ended 31 December 2015
24th Mar 20169:21 amRNSNotification of class 2 transaction
16th Mar 201610:01 amRNSNotice of Annual Results 2015
9th Mar 201610:04 amRNSStarry IPO
7th Mar 201610:34 amRNSLansen's release of its Trading Update
17th Feb 20168:50 amRNSLansen's Starry, obtains listing approval
29th Dec 20158:45 amRNSTrading Update
1st Dec 20155:51 pmRNSHolding(s) in Company
28th Aug 201510:12 amRNSHalf Yearly Report
17th Aug 20157:00 amRNSNotice of Interim Results
6th Jul 201510:25 amRNSLitigation against Lansen's sub in Ningbo, the PRC
15th Jun 20151:18 pmRNSLansen enters a distribution agreement with Botai
11th Jun 20159:38 amRNSDistribution agreement with Bio-Rad China
5th Jun 20157:01 amRNSAppointment of New Chairman
5th Jun 20157:00 amRNSResult of AGM
11th May 20157:00 amRNSAppointment of Broker
17th Apr 20159:03 amRNSTransaction in Own Shares
16th Apr 20153:44 pmRNSAnnual Report and Accounts
15th Apr 20158:59 amRNSTransaction in Own Shares
9th Apr 20157:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.